I love Townsend Letter and the articles you publish. I recently read your Letter from the Publisher, “The Fragile State of COVID-19 Science,” and felt a need to email you with a few of my thoughts. Both HCQ (hydroxychloroquine) and ivermectin, when added to other treatments, are very effective in early outpatient treatments.
1. Re your statement that “HCQ has not proven to be an effective drug”: The literature published by Peter McCullough, et al. says the opposite. [See “Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).” Rev Cardiovascular Med. 2020;21(4): 517-530]









0 Comments